adolescents ages 12 to 17 have obesity
2901 Johnston Street, Suite 300 Lafayette, Louisiana 70503 www.webreandassociates.com Phone: (337) 237-5051 | Fax: (337) 237-5061 Copyright 2025, Webre & Associates - All Rights Reserved
Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance
For more information, visit the NHS pages on 'Taking medicines abroad' and 'How to store medicines'
For many patients, mental energy and emotional resilience represent the most transformative benefits of the treatment journey
Jardiance has proven cardiovascular benefits, reducing the risk of cardiovascular death and hospitalisation for heart failure in high-risk patients, as recognised in NICE guidance (NG28)